FDA Grants Additional Six Months Marketing Exclusivity for the High Blood Pressure Medicine Diovan

Diovan (valsartan) has been granted pediatric exclusivity by the U.S. Food and Drug Administration (FDA) based on studies conducted in children with high blood pressure.
Asian Corporate News Network